Anteris Technologies Ltd
ASX:AVR.AX
Overview | Financials
Company Name | Anteris Technologies Ltd |
Symbol | AVR.AX |
Currency | AUD |
Price | 10.21 |
Market Cap | 215,837,358 |
Dividend Yield | 0% |
52-week-range | 9.3 - 23.93 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Mr. Wayne G. Paterson |
Website | https://www.anteristech.com |
An error occurred while fetching data.
About Anteris Technologies Ltd
Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD